[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Shares Traded Last Trade
  111.00 1.23% 9,114.00 689,030 13:53:42
Bid Price Offer Price High Price Low Price Open Price
9,113.00 9,115.00 9,149.00 9,018.00 9,060.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 19,468.19 2,864.24 178.47 51.4 141,186
Last Trade Time Trade Type Trade Size Trade Price Currency
13:53:31 O 10 9,114.535 GBX

Astrazeneca (AZN) Latest News

More Astrazeneca News
Astrazeneca Investors    Astrazeneca Takeover Rumours
Smart Money!
AZN is a large holding in the following funds:
 Fund  Percentage of Fund  Last Updated 
 EP GLOBAL OPPORTUNITIES TRUST PLC 2.30% 2020-11-30
 BLACKROCK INCOME AND GROWTH INVESTMENT TRUST PLC 6.90% 2021-09-30
 BMO CAPITAL AND INCOME INVESTMENT TRUST PLC 4.30% 2021-09-30
 JUPITER UK GROWTH INVESTMENT TRUST PLC 3.70% 2021-10-26
 JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC 6.00% 2021-09-30

Astrazeneca (AZN) Discussions and Chat

Astrazeneca Forums and Chat

Date Time Title Posts
26/10/202117:57AstraZeneca5,036
20/9/202115:45INDIA'S COVID DEATH RATE IS 278 PER 1 MILLION..UK'S IS 1876..THINK ABOUT IT1
15/9/202112:17Eu2
03/9/202116:44EU and AZN 3
24/6/202116:39ASTRAZENECA, MSD PROSTATE CANCER DRUG GETS CHINA GREEN LIGHT1

Add a New Thread

Astrazeneca (AZN) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
12:53:329,114.5410911.45O
12:53:069,114.00292,643.06AT
12:52:459,109.101,00091,091.04O
12:52:419,113.00908,201.70AT
12:52:229,115.00343,099.10AT
View all Astrazeneca trades in real-time

Astrazeneca (AZN) Top Chat Posts

DateSubject
27/10/2021
09:20
Astrazeneca Daily Update: Astrazeneca Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 9,003p.
Astrazeneca Plc has a 4 week average price of 8,565p and a 12 week average price of 8,029p.
The 1 year high share price is 9,149p while the 1 year low share price is currently 6,736p.
There are currently 1,549,116,129 shares in issue and the average daily traded volume is 1,177,909 shares. The market capitalisation of Astrazeneca Plc is £141,573,723,029.31.
21/10/2021
13:51
philanderer: J.P.Morgan keeps AstraZeneca as 'top pick' on growth outlook, undervaluation (Sharecast News) - AstraZeneca's growth outlook is the best in its sector and was not yet reflected in its share price, analysts at JP Morgan said following a 'deep dive' into the drug maker's financials. Hence their decision to keep the shares as their 'top pick' in the sector. In local currency terms, the broker estimated that the company's core earnings per share were set to grow by 33%, 27% and 23% between 2021-23 - excluding its Covid-19 vaccine. Subsequently, EPS was seen growing at a compound annual rate of growth of 9% over 2023-26. Furthermore, Astra was only trading on 14.5 times' its estimated core EPS for 2023, against its sector trading on 16.5 Yet the expected rate of growth in the drugmaker's core EPS across 2023-26 in compound annual terms was expected to be four percentage points higher thanks to its comparatively young on-market portfolio and deep late stage pipeline. "Given our forecast for a strong growth outlook, and the compelling valuation, we remain Overweight, with Astra remaining a top pick in the sector."
19/10/2021
08:21
arja: nothing helping the share price at present as it drifts slowly down .
11/10/2021
13:46
beckers2008: AstraZeneca : Deutsche Bank Boosts AstraZeneca's PT, Keeps PT 10/11/2021 | 01:23pm BST (MT Newswires) -- AstraZeneca (AZN.L, AZN.ST) on Monday raised its price target on AstraZeneca (AZN.L, AZN.ST) to 105 pounds sterling ($143.19) from 102 pounds and maintained its buy rating. The Anglo-Swedish pharmaceutical company's shares increased marginally on Monday midday.
29/9/2021
15:39
arja: nice pickup today . anyone who has followed AZN for a while know if USA or UK is lead market for this stock , IE after 2.30pm does AZN here react to movement of AZN in usa or the other way around ?? i think USA is lead market from price movements
10/9/2021
11:41
hjs: AZN has gone down as a result of their "Vaccine Booster" statement. Market will always react to any news to mark the share price up or down! this is my view.
16/8/2021
10:49
beckers2008: Catching Up, well it is summer! 12/08/2021. Analysts at JP Morgan resumed their coverage of AstraZeneca at 'overweight', telling clients they saw a "re-rating opportunity". Indeed, with approximately 20% upside now on offer, JP Morgan also named the shares its UK large-cap top-pick. The company's share price, with an implied core price-to-earnings multiple of 15.5 and 13.5 times' for 2022 and 2023, was failing to reflect the company's superior growth outlook. "We see Astra's sector discount unwinding, as the Alexion acquisition demonstrates continued strong top-line growth, coupled with significant operating margin expansion and increased free cash flow generation," they added. That was on top of a "number" of upcoming pipeline catalysts that the broker said could drive long-term upgrades and multiple expansion. On their 10,000.0p target price, Astra would merely re-rate to a 2023 sector multiple, JP Morgan said. Among those potential catalysts were phase III data from Lynparza's PROpel front line Prostate cancer trial, ALXN1840 for Wilson's disease and phase III data for Enhertu DESTINY-04 for HER2 intermediate/low breast cancer. The former two dats sets were expected in the back half of 2021 and the latter in the front half of 2022.
01/8/2021
09:09
waldron: CAMBRIDGE, Britain (AP) _ Astrazeneca PLC (AZN) on Thursday reported second-quarter profit of $550 million. The Cambridge, Britain-based company said it had profit of 21 cents per share. Earnings, adjusted for non-recurring costs, came to 45 cents per share. The pharmaceutical posted revenue of $8.22 billion in the period. Astrazeneca shares have increased 14% since the beginning of the year. The stock has climbed almost 1% in the last 12 months. This story was generated by Automated Insights (Http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AZN at Https://www.zacks.com/ap/AZN
29/6/2021
10:44
philanderer: Drug breakthroughs to drive AstraZeneca, says Berenberg Breast cancer drug Enhertu is expected to provide further upside in AstraZeneca (AZN) shares, says broker Berenberg. Analyst Luisa Hector retained her ‘buy’ recommendation and £95 target price on the shares, which closed up 2%, or 167p, at £86.66 on Monday. Hector said the share price had ‘largely recovered from its winter woes when the company’s Covid-19 vaccine and the proposed Alexion acquisition led to downward pressure’. She is expecting AstraZeneca to continue delivering returns on its research and development programme, in particular the investment in Enhertu, a medicine used to treat breast cancer that has spread to other parts of the body or cannot be removed by surgery. ‘Positive data readouts in the second half from pipeline assets such as Enhertu should drive further upside in the AstraZeneca share price as probabilities of success increase and sales are subject to upward revisions,’ she said. HTTPS://citywire.co.uk/funds-insider/news/expert-view-astrazeneca-jd-sports-petrofac-greggs-and-alpha-financial/a1524218?section=funds-insider&_ga=2.33020406.917469266.1624959738-1068178417.1624959738#i=2
09/6/2021
19:53
arja: bad news announcement and AZN share price rockets - hard to understand the market at times !
04/5/2021
10:36
stutes: I note how Alexion adr is around $170 level - below bid price. I don't buy into the recent increase while AZN share price remains below £85 to £100 range. Alexion needs AZN's cash to fund future r&d - time to renegotiate the bid price ?
Astrazeneca share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
AZN
Astrazenec..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211027 13:08:49